scholarly journals CGRP Receptor Antagonism in COVID-19: Potential Cardiopulmonary Adverse Effects

2021 ◽  
Vol 27 (1) ◽  
pp. 7-10
Author(s):  
Tom Skaria ◽  
Thomas Wälchli ◽  
Johannes Vogel
Keyword(s):  
Adverse Effects ◽  
Cgrp Receptor ◽  
Receptor Antagonism

CGRP Receptor Antagonism and Migraine Therapy

2013 ◽  
Vol 14 (5) ◽  
pp. 386-392 ◽  
Author(s):  
Lars Edvinsson ◽  
Karin Warfvinge
Keyword(s):  
Cgrp Receptor ◽  
Receptor Antagonism ◽  
Migraine Therapy

CGRP-Receptor Antagonism in Migraine Treatment

2007 ◽  
Vol 6 (4) ◽  
pp. 240-246 ◽  
Author(s):  
Lars Edvinsson ◽  
Kenneth Ahrend Petersen
Keyword(s):  
Migraine Treatment ◽  
Cgrp Receptor ◽  
Receptor Antagonism

scholarly journals Calcitonin Gene-Related Peptide Receptor Antagonists for Migraine Prophylaxis

2017 ◽  
Vol 52 (6) ◽  
pp. 406-407 ◽  
Author(s):  
Scot Walker
Keyword(s):  
Adverse Effects ◽  
Calcitonin Gene Related Peptide ◽  
Migraine Prophylaxis ◽  
Cgrp Receptor ◽  
Peptide Receptor ◽  
Related Peptide ◽  
Common Disorder ◽  
Calcitonin Gene ◽  
New Strategies ◽  
The U.S

Migraine is a common disorder affecting 12% of the U.S. population. Prophylaxis is recommended for patients who experience frequent migraines. Because current drugs used for prophylaxis are not 100% effective and cause adverse effects that affect compliance, new strategies have been studied to prevent headaches. One new pharmacologic strategy is to use an inhibitor of the calcitonin gene-related peptide (CGRP). As a class, the CGRP receptor inhibitors have reduced monthly migraine days and are well tolerated. This article will briefly review CGRP inhibitors in development.

Sigma-1 receptor antagonism as opioid adjuvant strategy: Enhancement of opioid antinociception without increasing adverse effects

2013 ◽  
Vol 711 (1-3) ◽  
pp. 63-72 ◽  
Author(s):  
Alba Vidal-Torres ◽  
Beatriz de la Puente ◽  
Maria Rocasalbas ◽  
Clara Touriño ◽  
Simona Andreea Bura ◽  
...  
Keyword(s):  
Adverse Effects ◽  
Receptor Antagonism ◽  
Sigma 1 Receptor ◽  
Sigma 1 ◽  
Opioid Antinociception

Effects of CGRP receptor antagonism on glucose and bone metabolism in mice with diet-induced obesity

Bone ◽  
2021 ◽  
Vol 143 ◽  
pp. 115646
Author(s):  
Paul Köhli ◽  
Jessika Appelt ◽  
Ellen Otto ◽  
Denise Jahn ◽  
Anke Baranowsky ◽  
...  
Keyword(s):  
Bone Metabolism ◽  
Cgrp Receptor ◽  
Receptor Antagonism ◽  
Diet Induced Obesity

CGRP/CGRP Receptor Antibodies: Potential Adverse Effects Due to Blockade of Neovascularization?

2019 ◽  
Vol 40 (1) ◽  
pp. 11-21 ◽  
Author(s):  
Masataka Majima ◽  
Yoshiya Ito ◽  
Kanako Hosono ◽  
Hideki Amano
Keyword(s):  
Adverse Effects ◽  
Cgrp Receptor ◽  
Receptor Antibodies

The adverse effects of pramipexole on probability discounting are not reversed by acute D2 or D3 receptor antagonism

2020 ◽  
Vol 32 ◽  
pp. 104-119 ◽  
Author(s):  
Marco Orrù ◽  
Hunter J. Strathman ◽  
Gabriele Floris ◽  
Simona Scheggi ◽  
Beth Levant ◽  
...  
Keyword(s):  
Adverse Effects ◽  
Probability Discounting ◽  
D3 Receptor ◽  
Receptor Antagonism

scholarly journals CGRP receptor antagonism and migraine

2010 ◽  
Vol 7 (2) ◽  
pp. 164-175 ◽  
Author(s):  
Lars Edvinsson ◽  
Tony W. Ho
Keyword(s):  
Cgrp Receptor ◽  
Receptor Antagonism

CGRP-receptor antagonism in migraine treatment

The Lancet ◽  
2008 ◽  
Vol 372 (9656) ◽  
pp. 2089-2090 ◽  
Author(s):  
Lars Edvinsson
Keyword(s):  
Migraine Treatment ◽  
Cgrp Receptor ◽  
Receptor Antagonism
Sign in / Sign up

Export Citation Format

Share Document